Inventor · disambiguated record
Robert J. Duguid
Also filed as: DUGUID ROBERT · DUGUID ROBERT J
13 granted patents·5 pending applications·56 citations·filing 1996–2024
90Inventor score
Files withMERCK SHARP & DOHME5MADRIGAL PHARMACEUTICALS INC4TRIUS THERAPEUTICS INC2VITAE PHARMACEUTICALS LLC2ARVINAS OPERATIONS INC1
Top patents by PatentIndex Score
18 records- 0195US9266861B2Method of synthesizing thyroid hormone analogs and polymorphs thereofMADRIGAL PHARMACEUTICALS INC·Filed 2015·Granted Feb 23, 2016·23 cites·17 claims
- 0294US11564926B2Methods of synthesizing thyroid hormone analogs and polymorphs thereofMADRIGAL PHARMACEUTICALS INC·Filed 2020·Granted Jan 31, 2023·4 cites·24 claims
- 0391US10894050B2Methods of synthesizing thyroid hormone analogs and polymorphs thereofMADRIGAL PHARMACEUTICALS INC·Filed 2019·Granted Jan 19, 2021·5 cites·12 claims
- 0480US2023210856A1Methods of synthesizing thyroid hormone analogs and polymorphs thereofMADRIGAL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0577US8580767B2Oxazolidinone containing dimer compounds, compositions and methods to make and useHESTER II D KEITH·Filed 2010·Granted Nov 12, 2013·6 cites·14 claims
- 0676US10913739B2Inhibitors of RORγVITAE PHARMACEUTICALS LLC·Filed 2018·Granted Feb 9, 2021·1 cites·6 claims
- 0776US9988406B2Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphateMERCK SHARP & DOHME·Filed 2017·Granted Jun 5, 2018·1 cites·2 claims
- 0876US8426389B2Crystalline form of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphateREICHENBAECHER KATHARINA·Filed 2010·Granted Apr 23, 2013·5 cites·27 claims
- 0975US8604209B2Methods for preparing oxazolidinones and compositions containing themWARE JACQUELINE A·Filed 2009·Granted Dec 10, 2013·5 cites·36 claims
- 1068US9328087B2Methods for preparing oxazolidinones and compositions containing themMERCK SHARP & DOHME·Filed 2013·Granted May 3, 2016·1 cites·7 claims
- 1166US10442829B2Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphateMERCK SHARP & DOHME·Filed 2018·Granted Oct 15, 2019·0 cites·1 claims
- 1266US10065947B1Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphateMERCK SHARP & DOHME·Filed 2018·Granted Sep 4, 2018·0 cites·2 claims
- 1363US2024409529A1Methods of Manufacturing a Bifunctional Compound, Ultrapure Forms of the Bifunctional Compound, and Dosage Forms Comprising the SameARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 1460US2021230158A1INHIBITORS OF RORgammaVITAE PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1559US9624250B2Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphateMERCK SHARP & DOHME·Filed 2015·Granted Apr 18, 2017·0 cites·27 claims
- 1657US5760210AProcess for the preparation of ribonucleotide reductase inhibitorsMERRELL PHARMA INC·Filed 1996·Granted Jun 2, 1998·5 cites·1 claims
- 1757US2013310343A1Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin- 5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphateTRIUS THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1848US2014057874A1Oxazolidinone containing dimer compounds, compositions and methods to make and useTRIUS THERAPEUTICS INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert J. Duguid files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →